The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
84642407 8464240 7 F 200104 20160726 20120316 20160801 EXP US-009507513-1203USA01842 MERCK 0.00 F Y 72.56000 KG 20160801 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
84642407 8464240 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, QW 20560 70 MG TABLET /wk
84642407 8464240 2 SS FOSAMAX ALENDRONATE SODIUM 1 Oral 10 MG, QD 20560 10 MG TABLET QD
84642407 8464240 3 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW 0 70 MG TABLET /wk
84642407 8464240 4 C EVISTA RALOXIFENE HYDROCHLORIDE 1 Oral 60 MG, QD U 0 60 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
84642407 8464240 1 Osteoporosis
84642407 8464240 3 Osteoporosis
84642407 8464240 4 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
84642407 8464240 OT
84642407 8464240 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
84642407 8464240 Acarodermatitis
84642407 8464240 Amnesia
84642407 8464240 Anaemia postoperative
84642407 8464240 Arthritis
84642407 8464240 Arthropod bite
84642407 8464240 Arthroscopic surgery
84642407 8464240 Asthma
84642407 8464240 Bronchitis
84642407 8464240 Chest discomfort
84642407 8464240 Colitis ulcerative
84642407 8464240 Constipation
84642407 8464240 Costochondritis
84642407 8464240 Deafness neurosensory
84642407 8464240 Dental prosthesis placement
84642407 8464240 Device failure
84642407 8464240 Diarrhoea
84642407 8464240 Femur fracture
84642407 8464240 Incision site erythema
84642407 8464240 Induration
84642407 8464240 Intramedullary rod insertion
84642407 8464240 Joint injury
84642407 8464240 Joint range of motion decreased
84642407 8464240 Laceration
84642407 8464240 Large intestine polyp
84642407 8464240 Meniscus injury
84642407 8464240 Oral surgery
84642407 8464240 Osteoarthritis
84642407 8464240 Sleep disorder
84642407 8464240 Vertigo
84642407 8464240 Wound infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
84642407 8464240 1 200109 200607 0
84642407 8464240 2 20001006 20010906 0
84642407 8464240 3 200903 201008 0
84642407 8464240 4 2006 0